Hydrogel pellet and preparation method thereof
By optimizing the preparation process of hydrogel microspheres and using a specific ratio of hydrogel framework materials and crosslinking agents to form a stable three-dimensional network structure, the problem of poor expansion performance of hydrogel microspheres was solved, and better gastric water absorption and swelling and drug release effects were achieved.
Patent Information
- Application Number
- CN202411006289.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
AI Technical Summary
Existing hydrogel microspheres have poor swelling properties, which affects their water absorption and swelling effect in the stomach and the uniformity of drug release.
Hydrogel microspheres were prepared by using a specific ratio of hydrogel framework material and crosslinking agent, combined with wetting agent, through extrusion, spheroidization and drying processes to form a stable three-dimensional network structure and improve its expansion performance.
It significantly improves the expansion performance and drug release uniformity of hydrogel microspheres, reduces treatment costs, enhances the sustained-release effect of drugs, and the material is safe, non-toxic, and biodegradable.
Smart Images

Figure CN118948805A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of food, health care products, medicines or medical devices, and in particular to a hydrogel micropill and a preparation method thereof. Background Art
[0002] Edible hydrogels have become a popular way to lose weight as gastric fillers. After entering the human stomach, edible hydrogels absorb water and swell, occupying space in the stomach, making the body feel full. They are not absorbed in the digestive system and do not provide any energy, reducing food intake and cutting off the body's energy supply, thereby achieving the purpose of weight loss. Compared with other weight loss methods, such as dieting and exercise, edible hydrogels are safe, efficient, and highly accepted by patients.
[0003] Micropellets are multi-unit drug delivery systems with a wide range of applications in the pharmaceutical, food, fertilizer, and fine chemical industries. They generally refer to spherical or quasi-spherical preparations with a diameter between 0.4 and 2.0 mm.
[0004] Chinese patent CN102266292B discloses a skeleton-type diclofenac potassium sustained-release micropellet capsule and its production process. The preparation method comprises the following steps: (1) uniformly mixing a prescribed amount of diclofenac potassium, a skeleton agent and a diluent to prepare a solid powder mixture; dissolving a prescribed amount of an antioxidant, an anti-adherent agent and an absorption promoter in a wetting agent to prepare a solution of a certain concentration; adding the above solution to the above solid powder mixture in batches, stirring and mixing to obtain a soft material; (2) adding the soft material to an extruder, setting a frequency of 10 to 100 Hz to extrude it into a strip, and then spheronizing it in a spheronizer at a frequency of 20 to 150 Hz for a spheronization time of 5 to 60 minutes, and drying to obtain a skeleton-type diclofenac potassium sustained-release micropellet; and (3) filling the skeleton-type diclofenac potassium sustained-release micropellet prepared in step (2) into a gastric-soluble capsule shell to obtain a skeleton-type diclofenac potassium sustained-release micropellet capsule. The method in the patent is a simple physical blending, that is, blending the hydrophilic gel skeleton carbomer and some auxiliary materials, and the swelling performance of the prepared hydrogel microcapsule capsule is poor. Summary of the invention
[0005] In view of the problem that the expansion performance of hydrogel micropill products in the prior art is poor, the present invention provides a hydrogel micropill and a preparation method thereof.
[0006] Compared with traditional single-dose drug delivery systems such as ordinary tablets, microcapsules have the following advantages: ① Microcapsules are evenly dispersed in the gastrointestinal tract, thereby improving the bioavailability of drugs and reducing the irritation of certain drugs to the gastrointestinal tract; ② It is independent of gastric emptying rate, resulting in less influence of food and individual differences on drug absorption and better reproducibility of absorption kinetics; ③ Since absorption kinetics is the sum of the release behaviors of many small units, defects or damage of a single microcapsule will not affect the release of the entire preparation, thereby reducing the risk of sudden release and having higher safety; ④ The properties of multi-unit drug loading meet the requirements of different doses and are conducive to the combination, storage and application of multiple active ingredients; ⑤ High production efficiency, large drug loading, energy saving and reduced waste of excipients, uniform product particle size and good content uniformity, good flowability, low friability and easy coating; ⑥ The microcapsules are coated using a multifunctional fluidized bed, which is widely used in the preparation of sustained-release drugs to achieve complex drug release curves.
[0007] In order to achieve the above technical purpose, the present invention provides a hydrogel micropill, the raw materials of which include a hydrogel skeleton material, a cross-linking agent and a wetting agent;
[0008] The hydrogel skeleton material is selected from one or more of chitosan and / or chitosan derivatives, starch and / or starch derivatives, carboxymethyl cellulose and / or carboxymethyl cellulose derivatives, pectin and / or pectin derivatives, heparin and / or heparin derivatives, hyaluronic acid and / or hyaluronic acid derivatives, chondroitin and / or chondroitin derivatives, alginic acid and / or alginic acid derivatives, konjac mannan and / or konjac mannan derivatives.
[0009] A product derived from the replacement of hydrogen atoms or atomic groups in a compound by other atoms or atomic groups is called a derivative.
[0010] Furthermore, the alginic acid derivative is sodium alginate; and / or the carboxymethyl cellulose derivative is sodium carboxymethyl cellulose.
[0011] Furthermore, the mass ratio of the hydrogel skeleton material to the cross-linking agent is 1:0.008-0.8, preferably 1:0.008-0.04, and more preferably 1:0.03.
[0012] Further, the hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan or a mixture of sodium carboxymethyl cellulose and sodium alginate; preferably, the hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 2-7:3-8 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 2-7:3-8; more preferably, the hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 7:3 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 7:3.
[0013] Furthermore, the raw materials of the hydrogel pellets also include drugs and / or nutrients;
[0014] Preferably, the drug is a weight loss drug;
[0015] Preferably, the nutrient is selected from one or more of spirulina, kale powder, and vitamin C;
[0016] Preferably, the mass ratio of the drug or nutrient to the hydrogel skeleton material is 0.05-200:1000; more preferably, the mass ratio of the drug to the hydrogel skeleton material is 0.05-100:1000; more preferably, the mass ratio of the nutrient to the hydrogel skeleton material is 1-10:1000.
[0017] Furthermore, the hydrogel pellets also satisfy one or more of the following AD:
[0018] A. The mass ratio of the hydrogel skeleton material to the wetting agent is 1:0.01-10;
[0019] B. The wetting agent is selected from one or more of water, ethanol, ethyl acetate, dichloromethane, n-propanol, and glycerol;
[0020] C. The raw materials of the hydrogel pellets also include an anti-adhesive agent; preferably, the mass ratio of the hydrogel skeleton material to the anti-adhesive agent is 0.5-1:0-0.01; preferably, the anti-adhesive agent is selected from one or more of talc, sodium stearyl fumarate, silicon dioxide, magnesium stearate, and titanium dioxide;
[0021] D. The cross-linking agent is selected from dibasic acid and / or tribasic acid.
[0022] The present invention also provides a method for preparing the hydrogel pellets, comprising: method 1, mixing and dissolving a hydrogel skeleton material and a crosslinking agent in the presence of water to obtain a mixed solution, drying the mixed solution, and obtaining a hydrogel material through a crosslinking reaction, and mixing the hydrogel material with a wetting agent to obtain a soft material; extruding, spheronizing, drying, and sieving the soft material to obtain hydrogel pellets;
[0023] Alternatively, in method 2, a hydrogel skeleton material, water, a crosslinking agent and a wetting agent are mixed to obtain a soft material; the soft material is subjected to a crosslinking reaction after being subjected to extrusion, spheronization, drying and sieving to obtain hydrogel pellets.
[0024] Furthermore, the preparation method of the hydrogel pellets satisfies one or more of the following AH:
[0025] A. In method 1 or method 2, the spheronization comprises the steps of first spheronizing at 13-17 rpm for 2-5 min, and then spheronizing at 55-65 rpm for 6-12 min;
[0026] B. In method 1 or method 2, the drying temperature after spheronization is 35-45°C;
[0027] C. In method 1 or method 2, the size of the sieve is 10-80 mesh; preferably, the size of the sieve is 25-40 mesh;
[0028] D. In method 1 or method 2, the cross-linking reaction temperature is 70-130°C and the time is 3-48h;
[0029] E. In method 2, the mass ratio of the hydrogel skeleton material to water is 0.008-0.8:100;
[0030] F. In method 2, drugs and / or nutrients are also mixed during mixing;
[0031] G. In method 1, the temperature of drying the mixed solution is 30-60°C and the time is 6-24h;
[0032] H. In method 1, the hydrogel skeleton material is mixed with a cross-linking agent aqueous solution; preferably, the mass percentage concentration of the cross-linking agent aqueous solution is 0.008-0.8%.
[0033] Furthermore, in method one, the mixed solution also includes medicines and / or nutrients.
[0034] Furthermore, in method one, before the hydrogel material is mixed with the wetting agent, the method also includes placing the hydrogel material in a solution containing drugs and / or nutrients for swelling and drying; preferably, the drying temperature is 70-100°C; preferably, the solvent in the solution containing drugs and / or nutrients is water; preferably, the mass percentage concentration of the solution containing drugs and / or nutrients is 0.00005-1%.
[0035] The present invention also provides a product, comprising the above hydrogel pellets or the hydrogel pellets prepared by the above preparation method;
[0036] Preferably, the type of the product is selected from one or more of medical devices, medicines, foods, and health products;
[0037] Preferably, the dosage form of the product is at least one selected from capsules and tablets.
[0038] The hydrogel capsule comprises the hydrogel microcapsules or the hydrogel microcapsules prepared by the preparation method of the hydrogel microcapsules.
[0039] Furthermore, the hydrogel capsule further comprises a capsule shell; the capsule shell comprises a film-forming material, a plasticizer and water;
[0040] Preferably, the hydrogel capsule further satisfies one or more of the following AC:
[0041] A, the plasticizer is selected from glycerol or sorbitol;
[0042] B. The film-forming material is at least one selected from gelatin, hydroxypropyl methylcellulose, sodium hydroxymethyl cellulose, plant cellulose, plant cellulose derivatives, and sodium alginate;
[0043] C. The capsule shell further comprises at least one of an anti-adherent and a pore-forming agent; more preferably, the anti-adherent agent is selected from one or more of talc, sodium stearyl fumarate, silicon dioxide, magnesium stearate, and titanium dioxide; more preferably, the pore-forming agent is selected from at least one of sucrose, an inorganic salt, polyethylene glycol, povidone, hydroxypropyl methylcellulose, and hydroxypropyl cellulose.
[0044] Furthermore, the hydrogel pellets are processed and packaged into hydrogel capsules through a capsule filling machine.
[0045] The salvia miltiorrhiza is selected from salvia miltiorrhiza powder or salvia miltio
[0046] The technical solution of the present invention has the following beneficial effects:
[0047] (1) The present invention provides a hydrogel micropill, wherein the raw materials of the hydrogel micropill include a hydrogel skeleton material, a crosslinking agent and a wetting agent; the hydrogel skeleton material is selected from one or more of chitosan and / or chitosan derivatives, starch and / or starch derivatives, carboxymethyl cellulose and / or carboxymethyl cellulose derivatives, pectin and / or pectin derivatives, heparin and / or heparin derivatives, hyaluronic acid and / or hyaluronic acid derivatives, chondroitin and / or chondroitin derivatives, alginic acid and / or alginic acid derivatives, konjac mannan and / or konjac mannan derivatives. The present invention uses a crosslinking agent, a wetting agent and a specific hydrogel skeleton material as raw materials for the hydrogel micropill, and the swelling performance of the prepared hydrogel micropill is greatly improved.
[0048] The hydrogel pellets prepared by the present invention construct cross-linking points between two-dimensional polymer segments to form a stable and strong three-dimensional network structure. Countless flexible and strong hydrogel mesh chambers continue to absorb water through the swelling of the hydrogel, so they have extremely strong water absorption and water lock capabilities in the stomach, thereby improving the expansion performance. Secondly, the pellets absorb water and swell in the gastrointestinal tract to form many small gel balls with a large total surface area. Due to the special shape of the gel balls, the spatial distance and gaps between the expanded gel balls are larger than other three-dimensional geometric bodies, which is more conducive to water absorption and expansion, and further improves the expansion performance.
[0049] (2) The hydrogel microcapsules provided by the present invention further improve the swelling performance of the hydrogel microcapsules by further limiting the mass ratio of the hydrogel skeleton material to the cross-linking agent to 1:0.008-0.04, preferably 1:0.03.
[0050] (3) The hydrogel microcapsules provided by the present invention further improve the swelling performance of the hydrogel microcapsules by further limiting the hydrogel skeleton material to a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 2-7:3-8 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 2-7:3-8; preferably a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 7:3 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 7:3.
[0051] (4) The present invention provides a method for preparing a hydrogel microcapsule, comprising: method 1, mixing and dissolving a hydrogel skeleton material and a crosslinking agent in the presence of water to obtain a mixed solution, drying the mixed solution, and obtaining a hydrogel material through a crosslinking reaction, mixing the hydrogel material with a wetting agent to obtain a soft material; extruding, spheronizing, drying, and sieving the soft material to obtain a hydrogel microcapsule; or, method 2, mixing a hydrogel skeleton material, water, a crosslinking agent, and a wetting agent to obtain a soft material; extruding, spheronizing, drying, and sieving the soft material to obtain a crosslinking reaction to obtain a hydrogel microcapsule. 1. After the hydrogel microcapsules prepared by the method of the present invention are swallowed, the microcapsules absorb water and swell in the gastrointestinal tract to form gel balls. Since the spatial distance and gap between the gel balls are larger than those of other three-dimensional geometric bodies, under the same conditions, a smaller amount of hydrogel microcapsules can be taken orally to achieve a full stomach, thereby reducing the consumption of drugs and the cost of treatment. 2. The drug is present in the hydrogel and is released slowly, which promotes the metabolism and consumption of body fat, reduces appetite, and can further reduce body weight. 3. The hydrogel microcapsules prepared by the extrusion spheronization process have a round and smooth surface and a small volume. After swelling, they are more flexible in distribution in the gastrointestinal tract, are not easy to agglomerate, and are more conducive to being excreted by the body. 4. The hydrogel microcapsules in the present invention use natural polymer compounds as hydrogel skeleton materials. They are safe and non-toxic after taking, and can be naturally degraded after the gastrointestinal effect is complete, without residue.
[0052] (5) The hydrogel capsule provided by the present invention has a very small particle size of hydrogel microcapsules contained therein, and swells more evenly and thoroughly in the stomach. It does not block the entry of water into the inner layer of the hydrogel microcapsules after the outer layer of the capsules with large particle sizes or other forms swells into gel, causing uneven swelling of the hydrogel microcapsules, reduced drug efficacy, and inhibition of drug digestion. Therefore, the hydrogel capsule prepared by the method of the present invention releases drugs more evenly during digestion in the gastrointestinal tract, has a wider range of action, and has better drug release kinetics and sustained-release effects.
[0053] (6) The present invention provides a method for preparing hydrogel microcapsules, which further improves the expansion performance of the hydrogel microcapsules by limiting the specifications of the sieve in the process of preparing the hydrogel microcapsules to a range of 25-40 meshes. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0055] Figure 1Schematic diagram of the structure of the hydrogel capsule prepared in Example 1 of the present invention.
[0056] Description of the accompanying drawings: 1. hydrogel micropellets; 2. capsule shell of the hydrogel capsule. DETAILED DESCRIPTION
[0057] The following examples are provided for a better understanding of the present invention, but are not intended to limit the best mode of implementation, nor to limit the content and protection scope of the present invention. Any product identical or similar to the present invention obtained by anyone under the inspiration of the present invention or by combining the features of the present invention with other prior arts shall fall within the protection scope of the present invention.
[0058] If no specific experimental steps or conditions are specified in the examples, the conventional experimental steps or conditions described in the literature in the field can be used. If no manufacturer is specified for the reagents or instruments used, they are all conventional reagent products that can be obtained commercially.
[0059] The capsule shell is selected from empty hydroxypropylmethylcellulose capsules (manufacturer: Hershey Capsules, models: No. 0, No. 00, No. 000) or empty gelatin capsules (manufacturer: Chengxin Pharmaceutical Capsules, model: No. 00). The capsule shells used in the following examples and comparative examples are all empty hydroxypropylmethylcellulose capsules (manufacturer: Hershey Capsules, model: No. 00).
[0060] Example 1
[0061] This embodiment provides a hydrogel pellet and a preparation method thereof and a hydrogel capsule, wherein the preparation method comprises the following steps:
[0062] S1. Pour 100 g of purified water into a stirring tank, add 0.008 g of citric acid, stir until fully dissolved, then add 1.0 g of sodium carboxymethyl cellulose, stir until fully dissolved, and obtain a mixed solution; place the mixed solution in an oven at 60° C. and dry for 6 hours to obtain a dry composite; then place the dry composite in an oven at 70° C. for cross-linking reaction for 48 hours to obtain a hydrogel material.
[0063] S2. Mix 0.5 g of hydrogel material, 0.01 g of n-propanol (wetting agent) and 0.002 g of magnesium stearate (anti-adhesive agent) to obtain a soft material; place the soft material in an extrusion spheronizer to extrude a thin strip material with uniform diameter (diameter 1.5 mm, length 2 mm), and then spheronize at 17 rpm for 5 min and 55 rpm for 12 min, then place the spheronized material in an oven and dry it at 35 ° C. After passing through a 20-mesh sieve, hydrogel micropills with a particle size of 0.8 mm were obtained.
[0064] S3. The hydrogel micropellets are loaded into capsule shells by a capsule filling machine at a loading amount of 0.65 g / piece to obtain hydrogel capsules.
[0065] The structure of the hydrogel capsule is shown in Figure 1 , including hydrogel pellets 1 and capsule shells 2 of hydrogel capsules.
[0066] Example 2
[0067] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that in Example 1, except that in step S1, "adding 0.008 g of citric acid" is replaced by "adding 0.03 g of citric acid".
[0068] Example 3
[0069] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that in Example 1, except that in step S1, "adding 0.008 g of citric acid" is replaced by "adding 0.04 g of citric acid".
[0070] Example 4
[0071] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that in Example 1, except that in step S1, "adding 0.008 g of citric acid" is replaced by "adding 0.06 g of citric acid".
[0072] Example 5
[0073] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that in Example 1, except that in step S1, "add 0.008 g citric acid" is replaced by "add 0.08 g citric acid".
[0074] Example 6
[0075] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 2, except that in step S1, "1.0 g sodium carboxymethyl cellulose" is replaced by "0.7 g sodium carboxymethyl cellulose and 0.3 g konjac mannan".
[0076] Example 7
[0077] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 2, except that in step S1, "1.0 g sodium carboxymethyl cellulose" is replaced by "0.5 g sodium carboxymethyl cellulose and 0.5 g konjac mannan".
[0078] Example 8
[0079] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 2, except that in step S1, "1.0 g sodium carboxymethyl cellulose" is replaced by "0.2 g sodium carboxymethyl cellulose and 0.8 g konjac mannan".
[0080] Example 9
[0081] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 2, except that in step S1, "1.0 g sodium carboxymethyl cellulose" is replaced by "0.7 g sodium carboxymethyl cellulose and 0.3 g sodium alginate".
[0082] Example 10
[0083] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 2, except that in step S1, "1.0 g sodium carboxymethyl cellulose" is replaced by "0.5 g sodium carboxymethyl cellulose and 0.5 g sodium alginate".
[0084] Embodiment 11
[0085] This embodiment provides a hydrogel pellet and a preparation method thereof and a hydrogel capsule, wherein the preparation method comprises the following steps:
[0086] S1. Pour 100g of purified water into a stirring tank, add 0.03g of citric acid (cross-linking agent), stir to fully dissolve to obtain a citric acid aqueous solution with a mass percentage concentration of 0.03%, then add 1g of sodium carboxymethyl cellulose (hydrogel skeleton material), stir to fully dissolve to obtain a mixed solution; place the mixed solution in an oven at 30°C and dry for 24h to obtain a dry composite; then place the dry composite in an oven at 130°C for cross-linking reaction for 48h to obtain a hydrogel sample.
[0087] S2. Add 0.5 mg of semaglutide (drug) into 100 g of water, stir to fully dissolve, and obtain a drug-containing aqueous solution with a mass percentage concentration of 0.0005%; then place the hydrogel sample prepared in step S1 in the drug-containing aqueous solution, and after swelling equilibrium, place it in an oven at 100°C to dry, thereby obtaining a drug-loaded hydrogel material.
[0088] S3. Mix 0.5 g of drug-loaded hydrogel material, 0.01 g of n-propanol (wetting agent), and 0.002 g of magnesium stearate (anti-adherent agent) to obtain a soft material; place the soft material in an extrusion spheronizer to extrude a thin strip material with uniform diameter (diameter 1.5 mm, length 2.0 mm), and then spheronize at 17 rpm for 5 min and 55 rpm for 12 min, then place the spheronized material in an oven and dry at 35°C, and pass through a 20-mesh sieve to obtain hydrogel micropellets with a particle size of 0.8 mm.
[0089] S4. The hydrogel micropellets are loaded into capsule shells by a capsule filling machine at a loading amount of 0.65 g / piece to obtain hydrogel capsules.
[0090] Example 12
[0091] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 11, with the only difference being that in step S2, "0.5 mg semaglutide" is replaced with "1 mg semaglutide".
[0092] Embodiment 13
[0093] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 11, with the only difference being that in step S2, "0.5 mg semaglutide" is replaced with "5 mg vitamin C".
[0094] Embodiment 14
[0095] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 11, with the only difference being that in step S2, "0.5 mg semaglutide" is replaced with "10 mg vitamin C".
[0096] Embodiment 15
[0097] This embodiment provides a hydrogel pellet and a preparation method thereof and a hydrogel capsule, wherein the preparation method comprises the following steps:
[0098] S1. Pour 50g of purified water into a stirring tank, add 0.015g of malic acid (cross-linking agent), stir to fully dissolve to obtain a malic acid aqueous solution with a mass percentage concentration of 0.03%, then add 0.5g of sodium carboxymethyl cellulose (hydrogel skeleton material), stir to fully dissolve to obtain a mixed solution; place the mixed solution in an oven at 30°C and dry for 24h to obtain a dry composite; then place the dry composite in an oven at 130°C for cross-linking reaction for 48h to obtain a hydrogel sample.
[0099] S2. Add 10 mg of Danshen powder (drug) into 50 g of water, stir until fully dissolved, and obtain a drug-containing aqueous solution with a mass percentage concentration of 0.02%; then place the hydrogel sample prepared in step S1 into the drug-containing aqueous solution, and after swelling equilibrium, place it in an oven at 100°C and dry it to obtain a drug-loaded hydrogel material.
[0100] S3. Mix 0.5 g of drug-loaded hydrogel material, 0.01 g of n-propanol (wetting agent), and 0.002 g of magnesium stearate (anti-adherent agent) to obtain a soft material; place the soft material in an extrusion spheronizer to extrude a thin strip material with uniform diameter (diameter 1.5 mm, length 2 mm), and then spheronize it at 17 rpm for 5 min and 55 rpm for 12 min, then place the spheronized material in an oven and dry it at 35°C, and pass it through a 20-mesh sieve to obtain hydrogel micropills with a particle size of 0.8 mm.
[0101] S4. The hydrogel micropellets are loaded into capsule shells by a capsule filling machine at a loading amount of 0.65 g / piece to obtain hydrogel capsules.
[0102] Example 16
[0103] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 15, except that in step S3, the hydrogel micropill with a particle size of 0.6 mm is obtained after passing through a 30-mesh sieve.
[0104] Embodiment 17
[0105] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 15, except that in step S3, the hydrogel micropill with a particle size of 0.25 mm is obtained after passing through a 60-mesh sieve.
[0106] Embodiment 18
[0107] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 16, with the only difference being that in step S1, "0.5 g sodium carboxymethyl cellulose" is replaced with "0.5 g sodium alginate".
[0108] Embodiment 19
[0109] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 16, with the only difference being that in step S1, "0.5 g sodium carboxymethyl cellulose" is replaced with "0.5 g konjac mannan".
[0110] Embodiment 20
[0111] This embodiment provides a hydrogel pellet and a preparation method thereof and a hydrogel capsule, wherein the preparation method comprises the following steps:
[0112] S1. Pour 50g of purified water into a stirring tank, add 0.15g of citric acid (cross-linking agent), stir to fully dissolve to obtain a citric acid aqueous solution with a mass percentage concentration of 0.3%, then add 0.5g of pectin (hydrogel skeleton material), stir to fully dissolve to obtain a mixed solution; place the mixed solution in an oven at 60°C and dry for 6h to obtain a dry composite; then place the dry composite in an oven at 70°C for cross-linking reaction for 3h to obtain a hydrogel sample.
[0113] S2. Add 100 mg of metformin (drug) to 50 g of water, stir to fully dissolve, and obtain a drug-containing aqueous solution with a mass percentage concentration of 0.2%; then place the hydrogel sample prepared in step S1 in the drug-containing aqueous solution, and after swelling equilibrium, place it in an oven at 70°C to dry, thereby obtaining a drug-loaded hydrogel.
[0114] S3. Mix 0.5 g of drug-loaded hydrogel, 0.01 g of ethanol (wetting agent), and 0.002 g of sodium stearyl fumarate (anti-adherent agent) to obtain a soft material; place the soft material in an extrusion spheronizer to extrude a thin strip material with uniform diameter (diameter 0.8 mm, length 1.2 mm), and then spheronize at 13 rpm for 2 min and 65 rpm for 6 min, then place the spheronized material in an oven and dry at 45°C, and pass through a 20-mesh sieve to obtain hydrogel micropellets with a particle size of 0.8 mm.
[0115] S4. The hydrogel micropellets are loaded into capsule shells by a capsule filling machine at a loading amount of 0.65 g / piece to obtain hydrogel capsules.
[0116] Embodiment 21
[0117] The present embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 20, except that step S1 and step S2 in Example 20 are modified as follows: 50 g of purified water is poured into a stirring tank, 0.15 g of citric acid (cross-linking agent) is added, and after stirring to fully dissolve, a citric acid aqueous solution with a mass percentage concentration of 0.30% is obtained, and then 0.5 g of pectin (hydrogel skeleton material) is added, and after stirring to fully dissolve, 100 mg of metformin (drug) is added, and after stirring to fully dissolve, a composite solution is obtained; the composite solution is placed in an oven at 60° C. and dried for 6 hours to obtain a dry composite; and the dry composite is placed in an oven at 70° C. for cross-linking reaction for 3 hours to obtain a drug-loaded hydrogel material.
[0118] Embodiment 22
[0119] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 16, with the only difference being that in step S1, "0.5 g sodium carboxymethyl cellulose" is replaced with "1 g sodium carboxymethyl cellulose", and "0.015 g malic acid" is replaced with "0.01 g malic acid".
[0120] Embodiment 23
[0121] This embodiment provides a hydrogel micropill and a preparation method thereof and a hydrogel capsule. The preparation method is basically the same as that of Example 16, with the only difference being that in step S1, "0.5 g sodium carboxymethyl cellulose" is replaced with "1 g sodium carboxymethyl cellulose", and "0.015 g malic acid" is replaced with "0.008 g malic acid".
[0122] Comparative Example 1
[0123] This comparative example provides a hydrogel pellet and a hydrogel capsule. The preparation method of the hydrogel pellet and the hydrogel capsule is basically the same as that of Example 16, except that in step S1, the hydrogel skeleton material is replaced by carbomer of the same mass instead of sodium carboxymethyl cellulose.
[0124] Comparative Example 2
[0125] This comparative example provides a hydrogel material, and the preparation method is basically the same as that of Example 5, except that steps S2 and S3 are not performed.
[0126] Comparative Example 3
[0127] This comparative example provides a hydrogel material, and the preparation method is basically the same as that of Example 21, except that steps S3 and S4 are not performed.
[0128] Experimental Example 1
[0129] The expansion performance of the hydrogel capsules prepared in Examples 1-10 and the hydrogel material prepared in Comparative Example 2 was measured. The expansion ratio and the time required for expansion equilibrium were measured.
[0130] The test method of the expansion ratio is as follows: take 1 hydrogel capsule, remove the capsule shell and place 0.65g of hydrogel pellets in 200mL of deionized water to obtain a mixed solution; alternatively, take 0.65g of hydrogel material and place it in 200mL of deionized water to obtain a mixed solution. Then immediately pour the mixed solution into a measuring cylinder and start timing from 0min (the hydrogel material or hydrogel pellets absorb water and become hydrogels and sink to the bottom of the measuring cylinder. When expanding, the volume increases, the density decreases, and the hydrogel floats up). Observe the height of the hydrogel in the measuring cylinder in real time. When the height of the hydrogel no longer increases, stop timing. The time at this time is the time required for expansion equilibrium. Then use a 100-mesh screen to filter, place the hydrogel particles above the screen in a beaker and weigh (peel the weight of the beaker), and the weight is recorded as W. e (g). Then the expansion ratio = W e / 0.65.
[0131] The test results are shown in Table 1. Compared with Comparative Example 2, the expansion performance of the hydrogel pellets prepared in Examples 1-10 is better, showing that the expansion ratio is between 102-234 times.
[0132] Among them, compared with Examples 4-5, Examples 1-3 limit the mass ratio of the hydrogel skeleton material and the cross-linking agent within the preferred range, further improving the expansion ratio of the hydrogel microcapsules; Example 2 Compared with Examples 1 and 3, Example 2 limits the mass ratio of the hydrogel skeleton material and the cross-linking agent within the preferred range, further improving the expansion ratio of the hydrogel microcapsules. Compared with Examples 7-8, Example 6 limits the mass ratio of sodium carboxymethyl cellulose to konjac mannan within the preferred range, further improving the expansion ratio of the hydrogel microcapsules. Compared with Example 10, Example 9 further improves the expansion ratio of the hydrogel microcapsules by limiting the mass ratio of sodium carboxymethyl cellulose to sodium alginate within the preferred range.
[0133] Table 1 Test results
[0134]
[0135]
[0136] Experimental Example 2
[0137] The swelling performance of the hydrogel capsules prepared in Examples 11-23 and Comparative Example 1 was measured. The swelling ratio and the time required for swelling equilibrium were measured in the same manner as in Experimental Example 1.
[0138] The test results are shown in Table 2 below. Compared with Comparative Example 1, the expansion ratio of the hydrogel pellets prepared in Examples 11-23 using konjac mannan, sodium alginate, pectin, and sodium carboxymethyl cellulose as hydrogel skeleton materials is significantly improved.
[0139] Compared with Examples 15 and 17, the expansion ratio of the hydrogel microcapsules prepared in Example 16 using a screen with a specification of 25-40 mesh is better.
[0140] Compared with Examples 18 and 19, the expansion ratio of the hydrogel microcapsules prepared in Example 16 using sodium carboxymethyl cellulose as the hydrogel skeleton material is better.
[0141] Compared with Example 21, Example 20 adopts the method of first preparing the hydrogel material, then preparing the hydrogel material loaded with drugs or nutrients, and finally preparing the microcapsules. The expansion ratio of the obtained hydrogel microcapsules is better.
[0142] The hydrogel pellets prepared by chemical crosslinking in the present invention present a stable three-dimensional network structure, are compact and strong, have a fast swelling rate when exposed to water, have strong water absorption performance, and have high swelling performance. Comparative Example 2 uses carbomer as a hydrogel skeleton material, which is only used as a drug sustained-release carrier, does not undergo a crosslinking reaction, does not form a three-dimensional crosslinked network water-binding structure, does not have a swelling effect when exposed to water, and has poor swelling performance.
[0143] Table 2 Test results
[0144]
[0145]
[0146] Experimental Example 3
[0147] The expansion performance of the hydrogel material prepared in Comparative Example 3 was measured. The expansion ratio and the time required for expansion equilibrium were measured in the same manner as in Experimental Example 1. The measurement results were compared with the results of the hydrogel pellets prepared in Example 21 in Experimental Example 2.
[0148] The results are shown in Table 3 below. Compared with Comparative Example 3, Example 21 uses hydrogel materials to prepare hydrogel microcapsules, which significantly improves the expansion ratio.
[0149] Table 3 Test results
[0150] Group Expansion ratio Time required for expansion equilibrium / min Embodiment 21 65 times 60 Comparative Example 3 56 times 62
[0151] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived therefrom are still within the scope of protection of the invention.
Claims
1. A hydrogel pellet, characterized in that: The raw materials of the hydrogel pellets include hydrogel skeleton material, cross-linking agent and wetting agent; The hydrogel skeleton material is selected from one or more of chitosan and / or chitosan derivatives, starch and / or starch derivatives, carboxymethyl cellulose and / or carboxymethyl cellulose derivatives, pectin and / or pectin derivatives, heparin and / or heparin derivatives, hyaluronic acid and / or hyaluronic acid derivatives, chondroitin and / or chondroitin derivatives, alginic acid and / or alginic acid derivatives, konjac mannan and / or konjac mannan derivatives.
2. The hydrogel pellet according to claim 1, characterized in that: The mass ratio of the hydrogel skeleton material to the cross-linking agent is 1:0.008-0.8, preferably 1:0.008-0.04, and more preferably 1:0.
03.
3. The hydrogel pellet according to claim 1 or 2, characterized in that: The hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan or a mixture of sodium carboxymethyl cellulose and sodium alginate; preferably, the hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 2-7:3-8 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 2-7:3-8; more preferably, the hydrogel skeleton material is a mixture of sodium carboxymethyl cellulose and konjac mannan in a mass ratio of 7:3 or a mixture of sodium carboxymethyl cellulose and sodium alginate in a mass ratio of 7:
3.
4. The hydrogel pellet according to any one of claims 1 to 3, characterized in that: The raw materials of the hydrogel pellets also include drugs and / or nutrients; Preferably, the drug is a weight loss drug; Preferably, the nutrient is selected from one or more of spirulina, kale powder, and vitamin C; Preferably, the mass ratio of the drug or nutrient to the hydrogel skeleton material is 0.05-200:1000; more preferably, the mass ratio of the drug to the hydrogel skeleton material is 0.05-100:1000; more preferably, the mass ratio of the nutrient to the hydrogel skeleton material is 1-10:1000.
5. The hydrogel pellet according to any one of claims 1 to 4, characterized in that: The hydrogel pellets also meet one or more of the following AD: A. The mass ratio of the hydrogel skeleton material to the wetting agent is 1:0.01-10; B. The wetting agent is selected from one or more of water, ethanol, ethyl acetate, dichloromethane, n-propanol, and glycerol; C. The raw materials of the hydrogel pellets also include an anti-adhesive agent; preferably, the mass ratio of the hydrogel skeleton material to the anti-adhesive agent is 0.5-1:0-0.01; preferably, the anti-adhesive agent is selected from one or more of talc, sodium stearyl fumarate, silicon dioxide, magnesium stearate, and titanium dioxide; D. The cross-linking agent is selected from dibasic acid and / or tribasic acid.
6. A method for preparing the hydrogel pellets according to any one of claims 1 to 5, characterized in that: The method comprises: method 1, mixing and dissolving a hydrogel skeleton material and a cross-linking agent in the presence of water to obtain a mixed solution, drying the mixed solution, and obtaining a hydrogel material through a cross-linking reaction; mixing the hydrogel material with a wetting agent to obtain a soft material; and extruding, spheronizing, drying, and sieving the soft material to obtain hydrogel pellets; Alternatively, in method 2, a hydrogel skeleton material, water, a crosslinking agent and a wetting agent are mixed to obtain a soft material; the soft material is subjected to a crosslinking reaction after being subjected to extrusion, spheronization, drying and sieving to obtain hydrogel pellets.
7. The method for preparing hydrogel pellets according to claim 6, characterized in that: The preparation method of the hydrogel pellets satisfies one or more of the following AH: A. In method 1 or method 2, the spheronization comprises the steps of first spheronizing at 13-17 rpm for 2-5 min, and then spheronizing at 55-65 rpm for 6-12 min; B. In method 1 or method 2, the drying temperature after spheronization is 35-45°C; C. In method 1 or method 2, the size of the sieve is 10-80 mesh; preferably, the size of the sieve is 25-40 mesh; D. In method 1 or method 2, the cross-linking reaction temperature is 70-130°C and the time is 3-48h; E. In method 2, the mass ratio of the hydrogel skeleton material to water is 0.008-0.8:100; F. In method 2, drugs and / or nutrients are also mixed during mixing; G. In method 1, the temperature of drying the mixed solution is 30-60°C and the time is 6-24h; H. In method 1, the hydrogel skeleton material is mixed with a cross-linking agent aqueous solution; preferably, the mass percentage concentration of the cross-linking agent aqueous solution is 0.008-0.8%.
8. The method for preparing hydrogel pellets according to claim 7, characterized in that: In method 1, the mixed solution also includes medicine and / or nutrient.
9. The method for preparing hydrogel pellets according to claim 7, characterized in that: In method one, before the hydrogel material is mixed with the wetting agent, the hydrogel material is placed in a solution containing drugs and / or nutrients for swelling and drying. Preferably, the drying temperature is 70-100°C. Preferably, the solvent in the solution containing drugs and / or nutrients is water. Preferably, the mass percentage concentration of the solution containing drugs and / or nutrients is 0.00005-1%.
10. A product, characterized in that The hydrogel pellets include any one of claims 1 to 5 or the hydrogel pellets prepared by the preparation method of any one of claims 6 to 9; Preferably, the type of the product is selected from one or more of medical devices, medicines, foods, and health products; Preferably, the dosage form of the product is at least one selected from capsules and tablets.
